Rifampicin Capsule Franchise in Ahmedabad

Rifampicin Capsule Supplier in Mumbai

Rifampicin Capsule Distributor in Delhi

Rifampicin Capsule Distributor in Delhi

Rifampicin Capsule Stockist in Hyderabad
Rifampicin Capsule Export & Manufacturing in Chandigarh

Home/Products /rifampicin-450mg-capsule

Rifamail 450 Capsule

Composition : Rifampicin (450mg) Capsule

Dosage Form : Capsule

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Rifamail 450 Capsule contains Rifampicin 450mg, a first-line anti-tuberculosis agent widely used for the treatment of TB and other bacterial infections. It plays a key role in combination therapy for effective TB management.

Rifampicin works by inhibiting bacterial RNA polymerase, stopping protein synthesis and promoting rapid bacterial clearance. Its efficacy in multi-drug TB regimens ensures optimal clinical outcomes.

Capsule formulation provides precise dosing, stable bioavailability, and easy administration, improving patient adherence. Due to its essential role in TB care, Rifamail 450 Capsule is in high demand across hospitals, clinics, and national TB programs.

Adding Rifamail 450 Capsule to your anti-tuberculosis and anti-infective portfolio strengthens your range with a trusted, high-rotation product. Its prescriber confidence, institutional use, and export potential make it ideal for PCD pharma companies, distributors, and third-party manufacturing partners.

Read More

About the Product

Rifamail 450 Capsule contains Rifampicin 450mg, a first-line anti-tuberculosis agent widely used for the treatment of TB and other bacterial infections. It plays a key role in combination therapy for effective TB management.

Rifampicin works by inhibiting bacterial RNA polymerase, stopping protein synthesis and promoting rapid bacterial clearance. Its efficacy in multi-drug TB regimens ensures optimal clinical outcomes.

Capsule formulation provides precise dosing, stable bioavailability, and easy administration, improving patient adherence. Due to its essential role in TB care, Rifamail 450 Capsule is in high demand across hospitals, clinics, and national TB programs.

Adding Rifamail 450 Capsule to your anti-tuberculosis and anti-infective portfolio strengthens your range with a trusted, high-rotation product. Its prescriber confidence, institutional use, and export potential make it ideal for PCD pharma companies, distributors, and third-party manufacturing partners.

Common side effects may include nausea, vomiting, loss of appetite, abdominal discomfort, mild diarrhea, and orange-red discoloration of urine, sweat, or tears. Rare but serious side effects include hepatotoxicity, thrombocytopenia, severe allergic reactions, or jaundice. Patients should seek immediate medical attention if severe or unusual symptoms occur.

Rifamail 450 Capsule is indicated for the treatment of tuberculosis, leprosy, and other infections caused by susceptible Mycobacterium species. It is usually prescribed as part of combination therapy to prevent resistance and ensure effective bacterial eradication, as advised by a healthcare professional.

Rifamail 450 Capsule should be taken exactly as prescribed, preferably on an empty stomach for maximum absorption. Completing the full course of therapy is crucial to prevent antibiotic resistance. Inform the physician about any history of liver or kidney disease, alcohol use, or concurrent medications.

Store Rifamail 450 Capsule in a cool, dry place away from direct sunlight. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation